Evaluation of Metamemory in Patients With Schizophrenia

NCT ID: NCT03338179

Last Updated: 2017-11-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-02-08

Study Completion Date

2016-05-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the respective roles of aging and schizophrenia in the regulation of metamemory using a generation strategy. 4 groups will be necessary to comparison:

Adult patients (18-45 years) Adult controls (18-45 years) Aged patients (≥ 59.5 years) Aged controls (≥ 59.5 years)

The effects of age and the disease could lead to interaction in regulating metamemory. The effect of age would be aggravated by the disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Metamemory measurement

* Objective: Measurement of monitoring and control capabilities, and relations between these two abilities when learning of word pairs.
* Description: The hardware consists of two lists of 30 pairs of French words, each pair of words being composed of a word index and a target word (names of concrete objects). Among the 60 word pairs, 30 are strongly associated items (or easy items, the other 30 being weakly associated or difficult items.

In front of a computer screen, each participant is subjected to a learning test in which 30 pairs of words appear one by one on the screen. Participants have the option to control the time of presentation of each pair of words. After a retention time of 4 minutes of information devoted to nonverbal distractive task, follows an evaluation phase of deferred judgments of learning (JOL time), where for each pair of words studied, the word index is presented without the target word. Participants must then assess a learning judgment for each pair of words, that is to say they have to estimate, on a 5-point scale, their ability to remember later the target word in the presentation the index word. This JOL assessment phase is immediately followed by cued recall test.

For the second learning test (30 other word pair), the steps are identical. Prior to this second learning, generating instruction of a pair of words to learn is proposed: a word index is presented to the participants who have to generate a pair with a target word. Participants are trained on 5 pairs of words.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Schizophrenia Aging

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Metamemory Schizophrenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

no masking

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adult Patients

Schizophrenia patients aged between 18 and 45 years old

Group Type EXPERIMENTAL

Judgement of learning evaluation

Intervention Type BEHAVIORAL

The hardware consists of two lists of 30 pairs of French words, each pair of words being composed of a word index and a target word (names of concrete objects). Among the 60 word pairs, 30 are strongly associated items (or easy items, the other 30 being weakly associated or difficult items.

Aged Patients

Schizophrenia patients aged 59.5 years and above

Group Type EXPERIMENTAL

Judgement of learning evaluation

Intervention Type BEHAVIORAL

The hardware consists of two lists of 30 pairs of French words, each pair of words being composed of a word index and a target word (names of concrete objects). Among the 60 word pairs, 30 are strongly associated items (or easy items, the other 30 being weakly associated or difficult items.

Adult Controls

Controls aged between 18 and 45 years old

Group Type ACTIVE_COMPARATOR

Judgement of learning evaluation

Intervention Type BEHAVIORAL

The hardware consists of two lists of 30 pairs of French words, each pair of words being composed of a word index and a target word (names of concrete objects). Among the 60 word pairs, 30 are strongly associated items (or easy items, the other 30 being weakly associated or difficult items.

Aged Controls

Controls aged 59.5 years and above

Group Type ACTIVE_COMPARATOR

Judgement of learning evaluation

Intervention Type BEHAVIORAL

The hardware consists of two lists of 30 pairs of French words, each pair of words being composed of a word index and a target word (names of concrete objects). Among the 60 word pairs, 30 are strongly associated items (or easy items, the other 30 being weakly associated or difficult items.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Judgement of learning evaluation

The hardware consists of two lists of 30 pairs of French words, each pair of words being composed of a word index and a target word (names of concrete objects). Among the 60 word pairs, 30 are strongly associated items (or easy items, the other 30 being weakly associated or difficult items.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* For both:
* Age: between 18 and 45 years for adults, and 59.55 and above for older,

For patients :

* DSM-5 criteria of schizophrenia
* Adult patients (\<45 years) will be matched to elderly patients (\> 59.55 years) gender and educational level,
* Patients followed as outpatients,
* Age of onset of the disease less than 40 years,
* Patients whose disease has stabilized: no changes psychotropic treatment for at least 1 month
* Not more of a benzodiazepine,
* Patients on protection of justice or not,

For controls :

* \- Matched for sex to patient
* Age-matched (+/- 3 years) to patient
* Matched for educational level (+/- 2 years) to patients

Exclusion Criteria

* -For patients :
* Any other comorbid psychiatric diagnosis of Axis I DSM-5 (particularly depression, addiction excluding tobacco, dementia)
* Patients with impaired vision or hearing preventing the realization of the tests.
* Long-term Anticholinergic treatment.
* Patients with less 5 years of school

For controls:

* Any psychiatric diagnosis according to DSM-5, including addictions (excluding tobacco)
* Head injuries, brain injuries or diseases,
* vision or hearing problems preventing the realization of the tests.
* Current or past addiction to all toxic substances except tobacco.
* Long-term Anticholinergic treatment.
* Related to the first degree diagnosed with a psychotic disorder
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

LAPSCO, Psychology University, Blaise Pascal University, Clermont-Ferrand.

UNKNOWN

Sponsor Role collaborator

University Hospital, Clermont-Ferrand

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Isabelle JALENQUES

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Clermont-Ferrand

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Clermont-Ferrand

Clermont-Ferrand, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2010-A00857-32

Identifier Type: OTHER

Identifier Source: secondary_id

CHU-360

Identifier Type: -

Identifier Source: org_study_id